Karagol Hacer Ilbilge Ertoy, Yilmaz Ozlem, Topal Erdem, Bideci Aysun, Bakirtas Arzu
Department of Pediatric Allergy and Asthma, Gazi University School of Medicine, Ankara, Turkey.
Allergy Asthma Proc. 2015 Nov-Dec;36(6):468-72. doi: 10.2500/aap.2015.36.3883.
The association between thyroid autoimmunity (TA) and idiopathic isolated angioedema (or angioedema without urticaria) has not been evaluated in either children or in adults up until now. We, therefore, aimed to investigate underlying or concomitant TA and/or autoimmune thyroid disease in children diagnosed with recurrent idiopathic angioedema.
Children who were consecutively diagnosed with recurrent idiopathic histaminergic acquired angioedema (IH-AAE) between January 2011 and January 2014 constituted the case group. A standard diagnostic and therapeutic algorithm was applied to all the patients with recurrent IH-AAE. Thyroid autoantibodies and thyroid function tests were measured in all the patients with recurrent IH-AAE and in healthy control groups. Prophylaxis with an antihistamine was started for patients with frequently recurrent IH-AAE.
Eighty consecutive children with recurrent IH-AAE (49 boys; median age, 8.3 years) and 80 healthy children (39 boys; median, 8 years) were enrolled in this prospective, case-control study (p > 0.05 for age and sex). The IH-AAE group was significantly different than the control group with respect to TA (13.7% versus 2.5%, respectively; p = 0.009) but was similar with respect to autoimmune thyroid disease (3.7% versus 0%, respectively; p = 0.2). The median follow-up of the recurrent IH-AAE group was 34 months (range, 12-45 months). Patients with recurrent IH-AAE with and those without TA were not different with respect to either the need or the duration of antihistamine prophylaxis (p > 0.05 for both).
Recurrent IH-AAE may be related to or associated with TA and/or autoimmune thyroid diseases in some children. However, exploring to see whether this association is a causal link or just an epiphenomenon deserves further investigation and longer follow-ups.
甲状腺自身免疫(TA)与特发性孤立性血管性水肿(或无荨麻疹的血管性水肿)之间的关联至今尚未在儿童或成人中进行评估。因此,我们旨在调查诊断为复发性特发性血管性水肿的儿童中潜在的或伴随的TA和/或自身免疫性甲状腺疾病。
2011年1月至2014年1月期间连续诊断为复发性特发性组胺能性获得性血管性水肿(IH-AAE)的儿童构成病例组。对所有复发性IH-AAE患者应用标准的诊断和治疗方案。对所有复发性IH-AAE患者和健康对照组进行甲状腺自身抗体和甲状腺功能测试。对频繁复发的IH-AAE患者开始使用抗组胺药进行预防。
80例连续的复发性IH-AAE儿童(49例男孩;中位年龄8.3岁)和80例健康儿童(39例男孩;中位年龄8岁)纳入了这项前瞻性病例对照研究(年龄和性别方面p>0.05)。IH-AAE组在TA方面与对照组有显著差异(分别为13.7%和2.5%;p=0.009),但在自身免疫性甲状腺疾病方面相似(分别为3.7%和0%;p=0.2)。复发性IH-AAE组的中位随访时间为34个月(范围12-45个月)。有TA和无TA的复发性IH-AAE患者在抗组胺药预防的需求或持续时间方面没有差异(两者p>0.05)。
在一些儿童中,复发性IH-AAE可能与TA和/或自身免疫性甲状腺疾病相关或有关联。然而,探究这种关联是因果关系还是仅仅是一种附带现象值得进一步研究和更长时间的随访。